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ABSTRACT
Purpose: To identify and assess, among the participants in the RENEB (Realizing the European
Network of Biodosimetry) project, the emergency preparedness, response capabilities and resources
that can be deployed in the event of a radiological or nuclear accident/incident affecting a large num-
ber of individuals. These capabilities include available biodosimetry techniques, infrastructure, human
resources (existing trained staff), financial and organizational resources (including the role of national
contact points and their articulation with other stakeholders in emergency response) as well as robust
quality control/assurance systems.
Materials and methods: A survey was prepared and sent to the RENEB partners in order to acquire
information about the existing, operational techniques and infrastructure in the laboratories of the dif-
ferent RENEB countries and to assess the capacity of response in the event of radiological or nuclear
accident involving mass casualties. The survey focused on several main areas: laboratory’s general
information, country and staff involved in biological and physical dosimetry; retrospective assays used,
the number of assays available per laboratory and other information related to biodosimetry and emer-
gency preparedness. Following technical intercomparisons amongst RENEB members, an update of the
survey was performed one year later concerning the staff and the available assays.
Conclusions: The analysis of RENEB questionnaires allowed a detailed assessment of existing capacity
of the RENEB network to respond to nuclear and radiological emergencies. This highlighted the key
importance of international cooperation in order to guarantee an effective and timely response in the
event of radiological or nuclear accidents involving a considerable number of casualties. The deploy-
ment of the scientific and technical capabilities existing within the RENEB network members seems
mandatory, to help other countries with less or no capacity for biological or physical dosimetry, or
countries overwhelmed in case of a radiological or nuclear accident involving a large number of
individuals.
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Introduction
Ionizing Radiation (IR) is widely used for medical, industrial,
environmental, energy generation and security applications.
Therefore, accidents/incidents involving IR can happen and
may involve a large number of potential casualties that need
to be categorized according to the degree of injury.
Furthermore, many countries use nuclear power as a source
of energy and an uncontrolled nuclear accident can have
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immediate (e.g. irradiation, injury and deterministic effects)
as well as long-term consequences that can lead to an
increased risk of developing radiation-induced diseases
(stochastic effects, e.g. cancer). Accidents like Chernobyl in
April 1986 involved large numbers of individuals (amongst
the population, the staff working in the nuclear power plant,
first responders and liquidators) that were exposed to the
radiation released. More recently, an earthquake and tsunami
resulted in the accident at the Fukushima Daiichi power
plant with over 1000,000 people affected. Malicious acts such
as a terrorist attack using radioactive sources, for example, a
Radiological Dispersal Device (RDD, dirty bomb) in a crowded
place or a concealed Radiological Exposure Device (RED) in
the public transportation system are also possible. Not to
mention the detonation of an Improvised Nuclear Device
(IND) over a populated area.
During the initial steps of emergency management in the
aftermath of such events, where triage and evaluation priori-
tize individuals according to their degree of injury and expos-
ure is fundamental, biodosimetry can be used to provide
timely assessments of radiation exposure since physical dos-
imetry is often not available or reliable (Kulka et al. 2012;
Maznyk et al. 2012).
Also the identification and reassurance of the large num-
ber of ‘worried well’ individuals is of paramount importance
in order to prevent the health care infrastructure from being
overwhelmed. Following a large-scale radiological incident,
fast medical and radiological triage of patients according to
the degree of radiation exposure will be required (Kulka
et al. 2015), with the number of people who may need to be
screened easily exceeding the capacity of a single or even
some laboratories. Networking has been recognized as a
sensible and important emergency response strategy after a
radiological accident in several regions of the world (Roy
et al. 2007). The already existing network Radiation
Emergency Medical Preparedness and Assistance Network
(REMPAN) from the World Health Organization (WHO) is one
good example. One of the critical factors related to the study
of biological effects of IR and widely distributed across the
body is the estimation of dose (Rodrigues et al. 2005) and
this is essential in an accident scenario. The majority of bio-
dosimetric studies use human lymphocytes, which besides
their availability are known to be very sensitive to IR.
Monitoring humans exposed to IR through biodosimetry has
relied heavily on the evaluation of cytogenetic indicators
such as unstable chromosomal aberrations, especially dicen-
tric chromosomes (considered the gold standard assay),
stable chromosomal aberrations, namely reciprocal transloca-
tions (using fluorescence in situ hybridization (FISH)/chromo-
some painting), and other cytogenetic biomarkers such as
micronuclei (MN), premature chromosome condensation
(PCC), or the c-H2AX assay for radiation-induced double-
strand breaks. With the exception of the c-H2AX assay, all of
these techniques are very time-consuming. Doses to individu-
als can also be estimated from dosimetric assays using elec-
tron paramagnetic resonance (EPR) and thermally – or
optically – stimulated luminescence (TSL, OSL) measurements
(Trompier et al. 2016). When the number of individuals
exposed is very high and/or a timely response is needed,
the capacity of a single laboratory can be overwhelmed.
These may be applied to biological materials such as teeth
(bio-physical assay), or to inorganic materials carried by
the individual such as components of their mobile phone
(physical assay). Such assays provide orientation to specific
dose estimates to complement whole body dose estimates
from biodosimetric assays.
The RENEB project (Realizing the European Network of
Biodosimetry) aimed to establish and develop a sustainable
European network in biological and physical dosimetry that
can be activated in case of an IR accident or incident. The
project included 23 institutions from 16 European countries.
This paper identifies the available equipment, techniques
and infrastructure in addition to the number of staff and
existing experience in each laboratory and the different
assays that are carried out. The capacities and capabilities of
these laboratories to respond to a radiological or nuclear
accident are summarized.
Materials and methods
A survey designed to evaluate capacity of response in the
event of a radiological accident was sent in February 2013 to
23 institutions of the RENEB consortium. The questionnaire
was designed to investigate several areas of information,
starting with questions about general information and the
kind of institution (hospital-based institute, military, national
institute of health, national research institute, radiation pro-
tection authority, or university-based institute). Also, ques-
tions about the research activities in biological and physical
dosimetry and/or emergency preparedness developed in
each laboratory and the available response capacity to an
accident were asked. The questionnaire also inquired about
the type of existing cooperation, if any, between the different
laboratories in the consortium. Questions about the research
activities developed by the members were included.
Specific questions about six biological assays (dicentric,
micronucleus, c-H2AX foci, FISH, M-FISH and PCC) and two
physical assays (EPR and OSL/TL) included the number of
persons involved in each assay, the equipment available and
existing experience in each laboratory which could be
offered and made available in the case of an accident involv-
ing exposure to IR. Responders to the survey could also spe-
cify other assays performed in the laboratory. The
questionnaire also collected data on the existence of other
laboratories in each country that could also perform the
same biological and/or physical techniques. In December
2014 a second questionnaire was sent to the RENEB
members in order to update the information on the capacity
of the network, in terms of human resources, assays
and techniques, for response to radiological emergencies.
Data from both surveys were compiled, analyzed and are
presented here.
Results
The results were obtained from the compilation of all the
information provided by the 17 institutions that answered
the questionnaire sent to the RENEB consortium. Table 1
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summarizes the types of institutions that answered the
questionnaire.
With regard to cooperation, some institutions already had
collaborations with other partners either through existing
projects/platforms (EURADOS, MULTIBIODOSE, WHO
BioDoseNet, WHO REMPAN, etc.) or through regular cooper-
ation as the 2004 established tripartite network between BfS,
PHE and IRSN. Also, biological dosimetry laboratories of
International Atomic Energy Agency (IAEA) member states
are improving the preparedness to react to radiation/nuclear
accidents at a national level and supporting if necessary the
neighbouring countries.
The analysis of the answers concerning the main areas of
research of the RENEB institutions in the field of biological or
physical dosimetry and/or emergency preparedness has
shown that the majority of laboratories are also involved in
research activities such as studies of control groups, radiation
qualities, radiation sensitivity, low dose effect, radiation acci-
dents, radiation protection, emergency preparedness, bio-
markers, DNA repair and automation of assays as shown in
Table 2. Other areas of interest are relative biological effective-
ness (RBE), radiotherapy patients, environmental exposure
and validation of methods and are also shown in Table 2.
Table 3 presents the number of laboratories using bio-
logical and physical dosimetry assays obtained in the first
questionnaire (2013). The second questionnaire (2014) was
created to evaluate the upgrade of capabilities of some
RENEB members following laboratory staff training and
courses in methodology, statistics or quality maintenance car-
ried out within the RENEB consortium.
By the analysis of Table 3, the dicentric assay ‘gold stand-
ard’ is the one that is most used, followed by the micronuclei
assay, whole chromosome painting and c-H2AX. It is also
clear that a difference exists between biological and physical
methods, with physical methods implemented less
frequently.
The survey showed that some laboratories have imple-
mented and have available more than one assay. Table 4
shows the number of available assays and the number of
laboratories using the biological (dicentric, MN, c-H2AX, PCC,
FISH, etc.) and the physical (EPR, OSL/TL) assays.
Table 5 shows the number of permanent and non-per-
manent staff, with the capability to conduct all the assays
and data analysis in each laboratory, along with the number
of samples that can be processed per week. Also shown in
Table 5 is the distribution of automatic equipment systems
among the laboratories involved in the RENEB network.
Table 2. Main areas of research activities of RENEB members.
Research area Number of institutions
Control group 16 (94%)
Radiation qualities 9 (53%)
Relative biological effectiveness 6 (35%)
Radiation sensitivity 15 (88%)
Low dose effect 11 (65%)
Radiotherapy patients 7 (41%)
Radiation accidents 13 (75%)
Environmental exposure 7 (41%)
Radiation protection 10 (59%)
Emergency preparedness 11 (65%)
Validation methods 13 (41%)
Biomarkers 14 (82%)
DNA repair 9 (53%)
Automation of assays 10 (59%)
Table 3. Number of institutions in the RENEB project perform-
ing biological and physical dosimetry assays.
Number of involved
laboratories
Biological assay 2013 2014
Dicentric 17 17
Micronucleus 11 13
c-H2AX 12 12
M-FISH 4 5
WCP 11 12
PCC 4 5
Physical assay
EPR 1 2
OSL/TL 3 4
M-FISH: multiplex fluorescence in situ hybridization; WCP: whole
chromosome painting; PCC: premature condensed chromo-
somes; EPR: electron paramagnetic resonance; OSL: optically
stimulated luminescence.
Table 1. Types of institutions involved in the RENEB project.
Type of institution Number of institutions
Civilian research institute 1 (5.9%)
Hospital based institute 2 (11.8%)
Military 1 (5.9%)
National institute of health 3 (17.6%)
National research institute 5 (29.4%)
Radiation protection authority 2 (11.8%)
University based institute 3 (17.6%)
Table 4. Number of available assays/laboratory taking into
account both biological and physical assays.
Number of assays per laboratory Number of laboratories
Biological assays
1 1
2 3
3 2
4 8
5 1
6 1
Physical assays
1 2
2 1
Table 5. Number of trained permanent and non-permanent staff, the number
of samples that can be analyzed per week and the number of automatic sys-
tems available inside the network.
Biological assay
Permanent
staff
Non-permanent
staff
Samples/
week
Automated
systems
Dicentric 43 18 2049 20
Micronucleus 25 11 1420 8
c-H2AX 20 13 3845 14
M-FISH 9 4 26 7
WCP 26 4 150 19
PCC 6 2 15 1
Bio-physical assay
EPR 5 1.5 850 –
OSL/TL 6 2.3 1200 5
M-FISH: multiplex fluorescence in situ hybridization; WCP: whole chromosome
painting; PCC: premature condensed chromosomes; EPR: electron paramag-
netic resonance; OSL/TL: optically stimulated luminescence. 800 sample in tri-
age mode.
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Table 6 presents the capacity of each country concerning
the available assays and the possible sample throughput per
week of each assay.
The survey also included questions about the number of
dose-response calibration curves implemented per assay tak-
ing into account different radiation qualities among the
RENEB laboratories (Figure 1). This is an important consider-
ation, as the interpretation of dose using a calibration curve
produced in another laboratory may introduce additional
uncertainty, and therefore any laboratory intending to carry
out biological dosimetry should establish its own dose-
response curve (IAEA 2011).
Most of laboratories (15) that perform the dicentric assay
have calibration curves for c radiation and 10 have calibra-
tion curves for X-rays, four for neutrons and just one for
a-particles. For the micronuclei assay, nine and four laborato-
ries have calibration curves for c and X-rays, respectively. For
c-H2AX only five laboratories have calibration curves for c
radiation and three for X-rays. For the FISH translocation
assay, based on whole chromosome painting, seven laborato-
ries have dose-response curves for c radiation and two for X-
rays; based on M-FISH just one out of four laboratories have
a dose-response curve for c radiation. One laboratory is just
establishing a calibration curve. In the case of the PCC assay,
two laboratories have calibration curves for c radiation and
one for X-rays.
There are four laboratories that also perform dose assess-
ment for new methods (gene expression, gene and protein
expression RT-QPCR, apoptosis and telomere length), and
two of them have dose-response curves for c radiation and
one for X-rays.
With regard to the physical assays, the laboratory that per-
forms EPR has a calibration curve for c/X-rays and laborato-
ries that perform OSL/TL all have calibration curves for
c/X-rays. In addition, one of them also has a calibration curve
for a-particles.
The questions related to the statistical method(s) and soft-
ware programmes used for dose assessment of the biological
assays, show that CABAS and Dose Estimate are the most
common software programmes for biological dosimetry: 11
laboratories use Dose Estimate, five use CABAS and five labo-
ratories use both programmes. Software packages such as R,
SPSS and ORIGIN are used by laboratories performing EPR
and OSL/TL.
Discussion
In the event of a large scale radiological/nuclear accident or
malevolent act using an RDD, RED or an IND, after the first
clinical triage of the casualties, it is very important to esti-
mate, with reasonable accuracy, the radiation dose to which
individuals have been exposed in order to anticipate the
development of stochastic or deterministic effects associated
with the radiation exposures. Biological and physical dosim-
etry can be used in a triage mode to help the initial clinical
evaluation as it allows the categorization of potentially
exposed individuals according to dose. Furthermore, it can
identify people exposed to a high dose, but also any ‘false
positives’, i.e. people that have not been exposed, but have
clinical symptoms that can be confused with those caused
by radiation exposure.
The RENEB project paved the way to establish a sustain-
able network involving European laboratories with experi-
ence, knowledge, skills and competence in biological and
physical assays, which can be used to perform triage dose
assessment for a high number of individuals in the event
of a large scale radiological emergency (as shown in Table
5). In addition to the accident simulation exercise that was
also performed in the framework of the RENEB project
Table 6. RENEB capacity per week concerning the different assays available
per country.
DIC MN c-H2AX M-FISH WCP PCC EPR OSL
Belgium 50 300 250 – – – – –
Bulgaria 70 200 0 – 49 – – –
Finland 50 – 60 – 15 – – –
France 1150 – 1400 10 30 – 800 250
Germany 140 550 110 1 6 – – –
Greece 20 – – 10 10 10 – –
Italy 55 50 5 5 15 5 50 300
Poland 40 120 10 – – – – –
Portugal 30 20 10 – 5 – – 650
Romania 4 20 0 – – – – –
Spain 90 – – – 10 – – –
UK 350 160 2000 – 10 – – –
Dic: dicentric; MN: micronuclei; M-FISH: multiplex fluorescence in situ hybrid-
ization; WCP: whole chromosome painting; PCC: premature condensed chro-
mosomes; EPR: electron paramagnetic resonance; OSL: optically stimulated
luminescence. in triage mode.
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Figure 1. Number of calibration curves implemented per assay, taking into account the radiation quality, in the RENEB laboratories. Dic: dicentric; MN: micronuclei;
M-FISH: multiplex fluorescence in situ hybridization; WCP: whole chromosome painting; PCC: premature condensed chromosomes; EPR: electron paramagnetic res-
onance; OSL/TL: optically stimulated luminescence.
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(Brzozowska et al. 2016), the maximum capacity of each
particular assay established in a laboratory, was identified.
The results collected and the analysis of the survey
showed the existence of a network featuring competence
and skills covering a wide range of biological and physical
dosimetry techniques. The analysis of the results of the
questionnaires pinpoint that there are a larger number of
laboratories performing biological assays, relative to the
corresponding number of those performing physical
techniques.
In order to ensure the accuracy and quality of the results
of individual laboratories and the comparability of results
between laboratories it is very important to establish a com-
mon methodology. This would need to encompass robust
quality assurance and quality management procedures, as
well as established, validated and documented protocols
(Gregoire et al. 2016). These procedures and protocols are
essential in order to have good laboratory practice through-
out the biological and physical dose assessment process
(Voisin 2015). For instance, the construction of calibration
curves, established in vitro, is very important as they allow
the conversion of a specific endpoint (e.g. dicentrics, micro-
nuclei, c-H2AX foci, etc.) into absorbed dose. In the group of
RENEB members almost all the laboratories involved have
these calibrations curves for at least one radiation quality
and for different assays. Concerning the physical assays, in
general these do not use predefined calibration curves:
instead at least one calibration point, or ideally an extended
calibration curve, is measured for each sample analysed. The
types of calibration curve that the laboratory uses therefore
depend on the availability of different irradiators in calibrated
geometries.
By compiling all of the survey data, it has been shown
that many of the laboratories involved in the RENEB network
have more than one assay operational and available. This is
ideal for a timely and fast dose assessment because the
response time of each test is rather variable. Indeed, for
example for c-H2AX and gene expression, results can be
obtained in the same day, while for dicentrics and micronu-
clei several days are required. The variability in the number
of available techniques, from 1–6 per laboratory, cover differ-
ent dosimetric aspects, as some assays are good after acute
exposure (dicentric, MN and c-H2AX), after chronical expos-
ure or long time ago (FISH translocations) or very high dose
exposures (PCC). Further aspects may be factors such as the
costs involved to improve and validate the assays, the influ-
ence of the costs and of the number of existing technicians
on the responsiveness to that assay, as well as the costs
associated to the need to get quick but good quality results.
It is also clear that for the more expensive assay, there are
fewer laboratories able to perform them or keep them
operational.
After the training courses performed in other RENEB labo-
ratories the response capability has been improved (Gregoire
et al. 2016, Wojcik et al. 2016). Moreover, it is important to
mention that the capacity of the assays increased drastically
with the network and that these assays can be used, e.g. for
clinical investigations in silent periods, which gives further
benefit to the community.
Conclusion
The sustainability of an international network of institutions
deploying technical and scientific skills and competence in
biodosimetry is of the utmost importance in the event of a
radiological or nuclear accident or malevolent act involving
mass casualties. In such scenarios, a single institution will be
overwhelmed and not be able to cope with the high number
of samples in time. An international infrastructure would
therefore be required and has been accomplished by the
RENEB project. However, this network still needs official rec-
ognition of the national and international organizations hold-
ing responsibilities for the management of the emergency
response to radiological and/or nuclear emergencies.
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